Arjun Balar MD
@ArjunBalarMD
Followers
1K
Following
7K
Media
15
Statuses
649
SVP - Global Clinical Development at @Lillypad; Former Director of GU Med Onc & CTO at NYU Langone PCC. UF 🐊 Alum; Personal Account.
New York, NY
Joined May 2018
RT @apolo_andrea: 📣 Last call!. Deadline extended to 12/15/24. Calling all #GU junior faculty & fellows! . Apply today for the 2025 GU Ear….
0
10
0
RT @MomsAGAbbott: Today is the 11-year mark of Sandy Hook and still nothing has changed. We just released this video @DemocracyMoms with ou….
0
4K
0
RT @Perlmutter_CC: Congratulations to our urologic oncology fellow Dr. Minas Economides (@minaseconomides), an #ASCO23 Young Investigator A….
0
8
0
RT @ScotNiglio: @minaseconomides, the future of NYU GU presenting our updated phase 2 trimodality pembro data at #ASCO23 .
0
1
0
You should be so proud Minas - I’m truly excited to see all that you will accomplish in the years ahead.
Honored to receive the ASCO YIA award. Once again grateful to my mentors @DrDaveWise @ArjunBalarMD and looking forward to meeting everyone next week in Chicago! @ConquerCancerFd @ASCO @Perlmutter_CC.
0
0
5
RT @jasonlukemd: Dean Bajorin is a legend & such an important figure in the lives/careers for so many oncologists. I'll be forever grateful….
0
7
0
RT @ASCO: We join the oncology community in mourning the loss of Dr. Nicholas J. Vogelzang, giant of GU oncology and past ASCO Board of Dir….
0
30
0
0
948
0
RT @NotoriousOHM: A furious, emotional and fed up Steve Kerr pleaded with senators to do something about the mass shootings. .
0
49K
0
RT @Prof_Nick_James: Absolutely - having complete TURBT as a requirement simply excludes higher stage patients who will of course have a si….
0
5
0
RT @OncLive: Trimodality Approach to MIBC Paves Path for Bladder Preservation @ArjunBalarMD #blcsm #oncology #MedTwitter .
onclive.com
Standard chemoradiation therapy regimens have had marked success for patients with muscle-invasive bladder cancer; however, up to 30% of patients who receive treatment with bladder preserving intent...
0
2
0
RT @bomani_jones: HAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAAHAHHAAHAHAHAHAHAHAHAHAHAAHAHAHAHAHA.
0
2K
0
RT @LoebStacy: Congrats to the amazing @angiesmith_uro on the 2022 @AmerUrological Gold Cystoscope Award! 👏👏👏 You are awesome! https://t.co….
0
24
0
🙏🏽.
@ArjunBalarMD & @Uromigos over 1st cup of Sunday coffee. Insights on.❇️ IO development in randomized trials.❇️ building GU referral center @nyulangone .❇️ making diffs in a new space @loxooncology .Your patients will miss you Arjun but glad we’re all still working together in GU!.
0
0
3
RT @jasonlukemd: So excited @US_FDA approved today anti-PD1 #immunotherapy pembrolizumab in high-risk stage IIB/C #melanoma! Tx to patients….
0
39
0
Always great to chat with @tompowles1 and @brian_rini.
Arjun Balar (who did the 1st podcast) describes his switch to industry as well as the Pembro trials he led in bladder cancer. @ArjunBalarMD
1
1
12